Rukobia (fostemsavir) | Friends of Cancer Research

You are here

Rukobia (fostemsavir)

Sponsor: 
ViiV Healthcare
Indication: 
Antiretroviral medication for adults living with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations.
Category: 
Year: 
2015
Date: 
Jul 21st
FDA Status: 
Designation Granted
Approval Date: 
Jul 2nd
Approval Year: 
2020